APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemotherapy-induced Nausea and Vomiting Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchChemotherapy-induced Nausea and Vomiting Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemotherapy-induced Nausea and Vomiting Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Chemotherapy-induced Nausea and Vomiting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemotherapy-induced Nausea and Vomiting Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Chemotherapy-induced Nausea and Vomiting Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chemotherapy-induced Nausea and Vomiting Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chemotherapy-induced Nausea and Vomiting Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chemotherapy-induced Nausea and Vomiting Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chemotherapy-induced Nausea and Vomiting Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Chemotherapy-induced Nausea and Vomiting Drugs include Eisai, Teva, Novartis, Merck, Mylan, Roche, Tesaro, Qilu Pharma and Mundipharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Chemotherapy-induced Nausea and Vomiting Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chemotherapy-induced Nausea and Vomiting Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Chemotherapy-induced Nausea and Vomiting Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chemotherapy-induced Nausea and Vomiting Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chemotherapy-induced Nausea and Vomiting Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Chemotherapy-induced Nausea and Vomiting Drugs sales, projected growth trends, production technology, application and end-user industry.

Chemotherapy-induced Nausea and Vomiting Drugs Segment by Company

Eisai

Teva

Novartis

Merck

Mylan

Roche

Tesaro

Qilu Pharma

Mundipharma

Heron Therapeutics

Chemotherapy-induced Nausea and Vomiting Drugs Segment by Type

5-HT3 Inhibitors

NK1 Inhibitors

Other

Chemotherapy-induced Nausea and Vomiting Drugs Segment by Application

Moderately Emetogenic Chemotherapy

Highly Emetogenic Chemotherapy

Low Emetogenic Chemotherapy

Other

Chemotherapy-induced Nausea and Vomiting Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotherapy-induced Nausea and Vomiting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemotherapy-induced Nausea and Vomiting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotherapy-induced Nausea and Vomiting Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Chemotherapy-induced Nausea and Vomiting Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Chemotherapy-induced Nausea and Vomiting Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemotherapy-induced Nausea and Vomiting Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5-HT3 Inhibitors Major Manufacturers Table 3. NK1 Inhibitors Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Moderately Emetogenic Chemotherapy Major Manufacturers Table 7. Highly Emetogenic Chemotherapy Major Manufacturers Table 8. Low Emetogenic Chemotherapy Major Manufacturers Table 9. Other Major Manufacturers Table 10. Chemotherapy-induced Nausea and Vomiting Drugs Industry Trends Table 11. Chemotherapy-induced Nausea and Vomiting Drugs Industry Drivers Table 12. Chemotherapy-induced Nausea and Vomiting Drugs Industry Opportunities and Challenges Table 13. Chemotherapy-induced Nausea and Vomiting Drugs Industry Restraints Table 14. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2021-2026) & (k units) Table 21. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2027-2032) & (k units) Table 22. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region (2021-2026) Table 23. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region (2027-2032) Table 24. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Chemotherapy-induced Nausea and Vomiting Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Chemotherapy-induced Nausea and Vomiting Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers, Product Type & Application Table 32. Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Chemotherapy-induced Nausea and Vomiting Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 42. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2027-2032) & (k units) Table 43. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Type (2021-2026) Table 44. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Type (2027-2032) Table 45. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2021-2026) & (US$/unit) Table 46. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2027-2032) & (US$/unit) Table 47. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2027-2032) & (k units) Table 55. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2021-2026) Table 56. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2027-2032) Table 57. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2021-2026) & (US$/unit) Table 58. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2027-2032) & (US$/unit) Table 59. Eisai Company Information Table 60. Eisai Business Overview Table 61. Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Eisai Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 63. Eisai Recent Development Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Teva Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 68. Teva Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Novartis Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 73. Novartis Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 78. Merck Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Mylan Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 83. Mylan Recent Development Table 84. Roche Company Information Table 85. Roche Business Overview Table 86. Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Roche Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 88. Roche Recent Development Table 89. Tesaro Company Information Table 90. Tesaro Business Overview Table 91. Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 93. Tesaro Recent Development Table 94. Qilu Pharma Company Information Table 95. Qilu Pharma Business Overview Table 96. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 98. Qilu Pharma Recent Development Table 99. Mundipharma Company Information Table 100. Mundipharma Business Overview Table 101. Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 103. Mundipharma Recent Development Table 104. Heron Therapeutics Company Information Table 105. Heron Therapeutics Business Overview Table 106. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio Table 108. Heron Therapeutics Recent Development Table 109. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 112. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2027-2032) & (k units) Table 113. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 114. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 115. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 118. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2027-2032) & (k units) Table 119. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 120. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 121. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 125. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 126. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2027-2032) & (k units) Table 127. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 128. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 129. United States Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 130. Canada Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 131. Mexico Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 132. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 135. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2027-2032) & (k units) Table 136. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 137. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 138. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 141. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2027-2032) & (k units) Table 142. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 143. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 144. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 149. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2027-2032) & (k units) Table 150. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 151. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 152. Germany Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 153. France Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 154. U.K. Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 155. Italy Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 156. Russia Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 157. Spain Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 159. Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 160. Sweden Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 161. Poland Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 162. China Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 163. China Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 164. China Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 165. China Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2027-2032) & (k units) Table 166. China Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 167. China Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 168. China Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 169. China Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 170. China Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 171. China Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2027-2032) & (k units) Table 172. China Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 173. China Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 174. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 175. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 176. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 177. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2027-2032) & (k units) Table 178. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 179. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 180. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 181. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 182. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 183. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2027-2032) & (k units) Table 184. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 185. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 186. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 190. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 191. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2027-2032) & (k units) Table 192. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 193. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 194. Japan Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 195. South Korea Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 196. India Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 197. Australia Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 198. Taiwan Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 199. Southeast Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 200. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 201. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 202. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (k units) Table 203. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2027-2032) & (k units) Table 204. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 205. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 206. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 207. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 208. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (k units) Table 209. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2027-2032) & (k units) Table 210. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 211. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 212. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 216. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (k units) Table 217. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2027-2032) & (k units) Table 218. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 219. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 220. Brazil Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 221. Argentina Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 222. Chile Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 223. Colombia Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 224. Peru Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 225. Saudi Arabia Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 226. Israel Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 227. UAE Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 228. Turkey Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 229. Iran Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 230. Egypt Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Chemotherapy-induced Nausea and Vomiting Drugs Distributors List Table 234. Chemotherapy-induced Nausea and Vomiting Drugs Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Chemotherapy-induced Nausea and Vomiting Drugs Image Figure 2. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5-HT3 Inhibitors Image Figure 5. NK1 Inhibitors Image Figure 6. Other Image Figure 7. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Moderately Emetogenic Chemotherapy Image Figure 10. Highly Emetogenic Chemotherapy Image Figure 11. Low Emetogenic Chemotherapy Image Figure 12. Other Image Figure 13. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (2021-2032) & (k units) Figure 19. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Chemotherapy-induced Nausea and Vomiting Drugs Sales YoY (2021-2032) & (k units) Figure 22. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales YoY (2021-2032) & (k units) Figure 23. China Chemotherapy-induced Nausea and Vomiting Drugs Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Chemotherapy-induced Nausea and Vomiting Drugs Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales YoY (2021-2032) & (k units) Figure 26. Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2021-2032) Figure 42. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2021-2032) Figure 43. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2021-2032) Figure 44. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2021-2032) Figure 45. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Country (2021-2032) Figure 46. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country (2021-2032) Figure 47. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2021-2032) Figure 49. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2021-2032) Figure 51. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country (2021-2032) Figure 53. China Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2021-2032) Figure 54. China Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2021-2032) Figure 55. China Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2021-2032) Figure 56. China Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2021-2032) Figure 57. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2021-2032) Figure 59. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2021-2032) Figure 61. Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Country (2021-2032) Figure 69. Chemotherapy-induced Nausea and Vomiting Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Chemotherapy-induced Nausea and Vomiting Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 5-HT3 Inhibitors
  • NK1 Inhibitors
  • Other
Applications
  • Moderately Emetogenic Chemotherapy
  • Highly Emetogenic Chemotherapy
  • Low Emetogenic Chemotherapy
  • Other
Companies covered
  • Eisai
  • Teva
  • Novartis
  • Merck
  • Mylan
  • Roche
  • Tesaro
  • Qilu Pharma
  • Mundipharma
  • Heron Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chemotherapy-induced Nausea and Vomiting Drugs Market by Type
  3. 1.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5-HT3 Inhibitors
  5. 1.2.3 NK1 Inhibitors
  6. 1.2.4 Other
  7. 1.3 Chemotherapy-induced Nausea and Vomiting Drugs Market by Application
  8. 1.3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Moderately Emetogenic Chemotherapy
  10. 1.3.3 Highly Emetogenic Chemotherapy
  11. 1.3.4 Low Emetogenic Chemotherapy
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Chemotherapy-induced Nausea and Vomiting Drugs Market Dynamics
  1. 2.1 Chemotherapy-induced Nausea and Vomiting Drugs Industry Trends
  2. 2.2 Chemotherapy-induced Nausea and Vomiting Drugs Industry Drivers
  3. 2.3 Chemotherapy-induced Nausea and Vomiting Drugs Industry Opportunities and Challenges
  4. 2.4 Chemotherapy-induced Nausea and Vomiting Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Region
  3. 3.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region
  9. 3.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers
  2. 4.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers
  6. 4.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Chemotherapy-induced Nausea and Vomiting Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market CR5 and HHI
  16. 4.8.2 2025 Chemotherapy-induced Nausea and Vomiting Drugs Tier 1, Tier 2, and Tier 3
5 Chemotherapy-induced Nausea and Vomiting Drugs Market by Type
  1. 5.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type
  2. 5.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type
  6. 5.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Type
6 Chemotherapy-induced Nausea and Vomiting Drugs Market by Application
  1. 6.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application
  2. 6.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application
  6. 6.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Application
7 Company Profiles
  1. 7.1 Eisai
  2. 7.1.1 Eisai Company Information
  3. 7.1.2 Eisai Business Overview
  4. 7.1.3 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  6. 7.1.5 Eisai Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Roche
  32. 7.6.1 Roche Company Information
  33. 7.6.2 Roche Business Overview
  34. 7.6.3 Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Roche Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  36. 7.6.5 Roche Recent Developments
  37. 7.7 Tesaro
  38. 7.7.1 Tesaro Company Information
  39. 7.7.2 Tesaro Business Overview
  40. 7.7.3 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  42. 7.7.5 Tesaro Recent Developments
  43. 7.8 Qilu Pharma
  44. 7.8.1 Qilu Pharma Company Information
  45. 7.8.2 Qilu Pharma Business Overview
  46. 7.8.3 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  48. 7.8.5 Qilu Pharma Recent Developments
  49. 7.9 Mundipharma
  50. 7.9.1 Mundipharma Company Information
  51. 7.9.2 Mundipharma Business Overview
  52. 7.9.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  54. 7.9.5 Mundipharma Recent Developments
  55. 7.10 Heron Therapeutics
  56. 7.10.1 Heron Therapeutics Company Information
  57. 7.10.2 Heron Therapeutics Business Overview
  58. 7.10.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Product Portfolio
  60. 7.10.5 Heron Therapeutics Recent Developments
8 North America
  1. 8.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type
  2. 8.1.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2021-2032)
  5. 8.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Application
  6. 8.2.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2021-2032)
  9. 8.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  10. 8.3.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type
  2. 9.1.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2021-2032)
  5. 9.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Application
  6. 9.2.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2021-2032)
  9. 9.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  10. 9.3.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type
  2. 10.1.1 China Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2021-2032)
  5. 10.2 China Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Application
  6. 10.2.1 China Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type
  2. 11.1.1 Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2021-2032)
  5. 11.2 Asia Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Application
  6. 11.2.1 Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2021-2032)
  9. 11.3 Asia Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  10. 11.3.1 Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Chemotherapy-induced Nausea and Vomiting Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type
  2. 12.1.1 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Application
  6. 12.2.1 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Country
  10. 12.3.1 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Chemotherapy-induced Nausea and Vomiting Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Chemotherapy-induced Nausea and Vomiting Drugs Value Chain Analysis
  2. 13.1.1 Chemotherapy-induced Nausea and Vomiting Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Chemotherapy-induced Nausea and Vomiting Drugs Production Mode & Process
  6. 13.2 Chemotherapy-induced Nausea and Vomiting Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Distributors
  9. 13.2.3 Chemotherapy-induced Nausea and Vomiting Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst